Jiangsu Kanion Pharmaceutical (600557.SH): Vice President Wu Yun resigns for personal reasons.

On July 18th, Gelunhui reported that Jiangsu Kanion Pharmaceutical (600557.SH) announced that the company's board of directors recently received a written resignation report submitted by Mr. Wu Yun, the company's deputy general manager. Due to personal reasons, Mr. Wu Yun applied to resign from his position as deputy general manager of the company. After resigning, Mr. Wu Yun will no longer hold any position in the company and its subsidiaries. As of the date of this announcement, Mr. Wu Yun holds 105,000 shares of the company's stocks, all of which are restricted stocks granted by the company's 2022 restricted stock incentive plan, with 60,000 shares still subject to restriction. The company will act in accordance with the 2022 Restricted Stock Plan to deal with restricted stocks.

Gelonghui FinanceJul 18 09:56 ET

Jiangsu Kanion Pharmaceutical (600557.SH): Has repurchased 0.966% of the shares.

On July 2, Glonhui reported that Jiangsu Kanion Pharmaceutical (600557.SH) announced that as of June 28, 2024, the company had repurchased a total of 5,619,989 shares, accounting for 0.9660% of the company's current total share capital. The highest price purchased was 19.98 yuan/share, the lowest was 15.62 yuan/share, and the total amount paid was 95,817,791.98 yuan (including transaction fees).

Gelonghui FinanceJul 2 05:14 ET

Jiangsu Kanion Pharmaceutical (600557.SH) director Chen Xuebin's relatives engaged in short-term trades and apologized.

Jiangsu Kanion Pharmaceutical (600557.SH) announced that Mr. Chen Xuebin, a director of the company, resigned due to the death of his spouse, Ms. Miao Jianbo, on 20...

Zhitong FinanceJun 21 05:49 ET

Jiangsu Kanion PharmaceuticalLtd's (SHSE:600557) Three-year Total Shareholder Returns Outpace the Underlying Earnings Growth

It hasn't been the best quarter for Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHSE:600557) shareholders, since the share price has fallen 26% in that time. But don't let that distract from the very n

Simply Wall StJun 19 23:15 ET

Jiangsu Kanion Pharmaceutical (600557.SH): has repurchased a total of 1.3137 million shares of stock.

On June 4th, Gelonghui announced that Jiangsu Kanion Pharmaceutical (600557.SH) has repurchased a total of 1,313,700 shares as of May 31, 2024, accounting for 0.2258% of the company's total share capital. The highest purchase price was 19.98 yuan/share and the lowest purchase price was 16.27 yuan/share. The total amount paid was 22,740,711.37 yuan (including transaction costs).

Gelonghui FinanceJun 4 06:09 ET

Does Jiangsu Kanion PharmaceuticalLtd (SHSE:600557) Deserve A Spot On Your Watchlist?

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. Sometime

Simply Wall StMay 27 20:41 ET